Post-Market Clinical Follow Up Study With Navitor Valve
VISTA Nova Study (Navitor Post-Market Clinical Follow Up Study)
Abbott Medical Devices
1,000 participants
Sep 29, 2023
OBSERVATIONAL
Conditions
Summary
Evaluation of the safety and performance of the Navitor TAVI System in a Global Study
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects will undergo transcatheter aortic valve replacement (TAVR) with the Navitor valve, the FlexNav Delivery system and the Navitor Loading System
Locations(50)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06008080